HIGHLIGHTS
SUMMARY
Inflammation, phagocytosis, proliferation, differentiation, and apoptosis (Monastyrskaya et_al, 2009; Xia et_al, 2020). ANXA1 has been extensively studied in gastric cancer and breast cancer (Maschler et_al, 2010; Cheng et_al, 2012). Some studies in gliomas have shown that ANXA1 is a risk prognostic factor (Xu et_al, 2017; Luo et_al, 2021; Wei et_al, 2021) Therefore, the authors investigated the expression, prognosis, and related mechanisms of ANXA1 using a public database to provide new markers and potential therapeutic targets for glioma patients. The therapeutic effect is limited with conventional treatment of gliomas, including complete surgical resection and postoperative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.